Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Secretoglobin family 2A member 1 (SCGB2A1), commonly known as mammaglobin-B, is a small secreted protein encoded by the SCGB2A1 gene on chromosome 11. Highly expressed in specific glandular tissues such as breast, uterus, and prostate, SCGB2A1 may bind androgens and steroid hormones, suggesting a role in hormonal regulation. Its expression is upregulated in various cancers, including ovarian, endometrial, and breast tumors, making it a potential antigen for immunotherapy and a candidate biomarker for cancer prognosis and detection. While its precise biological function remains incompletely understood, evidence supports roles in steroid hormone modulation, cell proliferation, and lipid metabolism. SCGB2A1 interacts with chemotherapeutic agents like estramustine and participates in tumor immune responses via cytotoxic T lymphocyte recognition[1][2][3][4][5][6].
Immunotherapy target: SCGB2A1-expressing tumor cells can be lysed by cytotoxic T lymphocytes in ovarian cancer[5]; Possible modulation of steroid hormone signaling (indirectly influences androgen/estrogen pathways)[2][3]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Secretoglobin family 2A member 1 (SCGB2A1).